Scaling for Commercial Success: Accelerating Late-Stage Biologics Through Platform-Based Manufacturing

Moving a biologics program from late-stage development to commercial manufacturing introduces new challenges around technology transfer, scale-up, supply continuity, regulatory readiness, and capacity planning. Addressing these factors early can help prevent costly delays as production requirements increase.

Explore how platform-based manufacturing strategies can simplify technology transfer, support efficient scale-up, and improve process consistency during the transition to commercialization. Practical insights from late-stage and commercial programs highlight how manufacturers can anticipate capacity constraints, strengthen supply chain readiness, and align infrastructure investments with future demand.

Learn which considerations can help reduce technical and operational risk while maintaining quality, compliance, and reliable product supply as biologics programs grow.